ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,042,000 | -13.0% | 50,000 | 0.0% | 0.59% | -11.0% |
| Q2 2023 | $1,197,500 | +27.3% | 50,000 | 0.0% | 0.66% | +2.3% |
| Q1 2023 | $941,000 | +18.2% | 50,000 | 0.0% | 0.65% | -17.4% |
| Q4 2022 | $796,000 | -33.8% | 50,000 | -2.9% | 0.79% | +124.6% |
| Q4 2021 | $1,202,000 | -1.6% | 51,500 | -29.9% | 0.35% | +12.9% |
| Q3 2021 | $1,221,000 | +271.1% | 73,500 | +444.4% | 0.31% | +248.3% |
| Q2 2021 | $329,000 | +161.1% | 13,500 | +474.5% | 0.09% | +67.9% |
| Q4 2020 | $126,000 | -3.1% | 2,350 | -25.4% | 0.05% | -15.9% |
| Q3 2020 | $130,000 | – | 3,150 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |